Jonathan Javitt

Insider Reports History

Location
Wilmington, DE
Signature
/s/ Jonathan Javitt
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Javitt:

Company Role Class Num Shares Value Price $ Report Date Ownership
NRX Pharmaceuticals, Inc. Chairman and Chief Scientist, Director, 10%+ Owner Common Stock 1,260,000 $1,474,200 $1.17 17 Dec 2024 By the Jonathan Javitt Living Trust
NRX Pharmaceuticals, Inc. Chairman and Chief Scientist, Director, 10%+ Owner Common Stock 142,200 $166,374 $1.17 17 Dec 2024 By the Javitt 2012 Irrevocable Dynasty Trust
NRX Pharmaceuticals, Inc. Chairman and Chief Scientist, Director, 10%+ Owner Common Stock 84,634 $99,022 $1.17 17 Dec 2024 Direct
NRX Pharmaceuticals, Inc. Chairman and Chief Scientist, Director, 10%+ Owner Common Stock 30,000 $35,100 $1.17 17 Dec 2024 By the Jonathan Javitt Donor Advised Fund
NRX Pharmaceuticals, Inc. Chairman and Chief Scientist, Director, 10%+ Owner Stock Option (right to buy) 125,000 09 Apr 2025 Direct

Insider Reports Filed by Jonathan Javitt

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NRXP NRX Pharmaceuticals, Inc. 09 Apr 2025 1 $0 4 Chairman and Chief Scientist, Director, 10%+ Owner 10 Sep 2025, 15:36
NRXP NRX Pharmaceuticals, Inc. 17 Dec 2024 1 +$46,800 4 Chairman and Chief Scientist, Director, 10%+ Owner 18 Dec 2024, 08:27
NRXP NRX Pharmaceuticals, Inc. 23 Aug 2023 1 +$33,000 4 Chief Scientist, Director, 10%+ Owner 24 Aug 2023, 13:14
NRXP NRX Pharmaceuticals, Inc. 22 Aug 2023 1 +$64,400 4 Chief Scientist, Director, 10%+ Owner 23 Aug 2023, 10:24
NRXP NRX Pharmaceuticals, Inc. 31 Dec 2022 1 $0 5 Director, 10%+ Owner 14 Feb 2023, 16:14
NRXP NRX Pharmaceuticals, Inc. 07 Dec 2022 1 -$400,000 4 Director, 10%+ Owner 09 Dec 2022, 15:33
NRXP NRX Pharmaceuticals, Inc. 01 Jun 2022 1 +$58,000 4/A Chief Scientist, Director, 10%+ Owner 02 Jun 2022, 09:46
NRXP NRX Pharmaceuticals, Inc. 24 May 2021 3 $0 4 Chief Executive Officer, Director, 10%+ Owner 10 Jun 2021, 18:48
NRXP NRX Pharmaceuticals, Inc. 24 May 2021 0 $0 3 Chief Executive Officer, Director, 10%+ Owner 10 Jun 2021, 18:32